The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545

Neutrophil Emigration in the Skin, Lungs, and Peritoneum: Different Requirements for CD11/CD18 Revealed by CD18-deficient Mice

Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750

An endotoxin-induced serum factor that causes necrosis of tumors

Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532

Coronaviruses: An Overview of Their Replication and Pathogenesis

Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243

COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions

Khan, W. H., Hashmi, Z., Goel, A., Ahmad, R., Gupta, K., Khan, N., Alam, I., Ahmed, F., & Ansari, M. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.690621 · Cited by 105

The cytokine storm and thyroid hormone changes in COVID-19

Croce, L., Gangemi, D., Ancona, G., Liboà, F., Bendotti, G., Minelli, L., & Chiovato, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01506-7 · Cited by 103

Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device

Jagannath, B., Lin, K., Pali, M. L., Sankhala, D., Muthukumar, S., & Prasad, S. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10220 · Cited by 104

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19

Peter, A. E., Sandeep, B. V., Rao, B. G., & Kalpana, V. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.583777 · Cited by 106

Variants in ACE2; potential influences on virus infection and COVID-19 severity

Bakhshandeh, B., Sorboni, S. G., Javanmard, A., Mottaghi, S. S., Mehrabi, M., Sorouri, F., Abbasi, A., & Jahanafrooz, Z. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104773 · Cited by 101

COVID-19 Vaccine in Pregnant and Lactating Women: A Review of Existing Evidence and Practice Guidelines

Garg, I., Shekhar, R., Sheikh, A. B., & Pal, S. (2021) · Infectious Disease Reports · doi:10.3390/idr13030064 · Cited by 104

The role of oxidative stress in the pathogenesis of infections with coronaviruses

Gain, C., Song, S., Angtuaco, T., Satta, S., & Kelesidis, T. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1111930 · Cited by 104

Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions

Kruglikov, I. L., Shah, M., & Scherer, P. E. (2020) · eLife · doi:10.7554/elife.61330 · Cited by 98

Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis

Liu, X., Wang, H., Shi, S., & Xiao, J. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2021-139939 · Cited by 98

Carvone and its pharmacological activities: A systematic review

Pina, L. T. S., Serafini, M. R., Oliveira, M. A., Sampaio, L. A., Guimarães, J. O., & Guimarães, A. G. (2022) · Phytochemistry · doi:10.1016/j.phytochem.2021.113080 · Cited by 101

Thromboembolic events and Covid-19

Ribes, A. M., Bounes, F. V., Mémier, V., Poette, M., Au-Duong, J., Garcia, C., Minville, V., Siè, P., Bura-Rivière, A., Voisin, S., et al. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100735 · Cited by 97

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives

Vargas, G., Geraldo, L. H., Salomão, N. G., Paes, M. V., Lima, F. R. S., & Gomes, F. C. A. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100127 · Cited by 97

Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection

Prozan, L., Shusterman, E., Ablin, J. N., Mitelpunkt, A., Weiss‐Meilik, A., Adler, A., Choshen, G., & Kehat, O. (2021) · Scientific Reports · doi:10.1038/s41598-021-00927-x · Cited by 94

COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue

Xi, Y. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1884503 · Cited by 93

Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression

Zheng, H., Li, H., Guo, L., Liang, Y., Li, J., Wang, X., Hu, Y., Wang, L., Liao, Y., Yang, F., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008949 · Cited by 94

A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS

Mackay, A. V. P. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.701419 · Cited by 95

Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective

Lee, C.-H., & Choi, W. J. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01301-7 · Cited by 93

COVID-19: Neurological Considerations in Neonates and Children

Stafstrom, C. E., & Jantzie, L. L. (2020) · Children · doi:10.3390/children7090133 · Cited by 92

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Altay, O., Arif, M., Li, X., Yang, H., Aydın, M., Alkurt, G., Kim, W., Akyol, D., Zhang, C., Dinler‐Doganay, G., et al. (2021) · Advanced Science · doi:10.1002/advs.202101222 · Cited by 88

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

Pum, A., Ennemoser, M., Adage, T., & Kungl, A. J. (2021) · Biomolecules · doi:10.3390/biom11010091 · Cited by 89

SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives

Ruggeri, R. M., Campennì, A., Deandreis, D., Siracusa, M., Tozzoli, R., Ovčariček, P. P., & Giovanella, L. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1932467 · Cited by 90

The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review

Aucoin, M., Cooley, K., Saunders, P. R., Cardozo, V., Remy, D., Cramer, H., Abad, C. N., & Hannan, N. (2020) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2020.07.007 · Cited by 86

Anti‐inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID‐19 therapy

Citi, V., Martelli, A., Brancaleone, V., Brogi, S., Gojon, G., Montanaro, R., Morales, G. A., Testai, L., & Calderone, V. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15230 · Cited by 85

Does COVID-19 infection influence patients’ performance during IVF-ET cycle?: an observational study

Orvieto, R., Segev-Zahav, A., & Aizer, A. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1918080 · Cited by 85

A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19)

Khatiwada, S., & Subedi, A. (2021) · Current Nutrition Reports · doi:10.1007/s13668-021-00354-4 · Cited by 85

Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host

Lloréns‐Rico, V., Gregory, A., Weyenbergh, J. V., Jansen, S., Buyten, T. V., Qian, J., Braz, M., Menezes, S. M., Mol, P. V., Vanderbeke, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26500-8 · Cited by 84

Whole‐Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID‐19 Patients

Li, C., Chen, J., Lv, S.-K., Li, J., Li, L., & Hu, X. (2021) · Mediators of Inflammation · doi:10.1155/2021/6635925 · Cited by 83

Neurological Complications of COVID-19: Underlying Mechanisms and Management

Shehata, G. A., Lord, K. C., Grudzinski, M. C., Elsayed, M., Abdelnaby, R., & Elshabrawy, H. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084081 · Cited by 84

Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells

Lehmann, M., Allers, K., Heldt, C., Meinhardt, J., Schmidt, F., Rodriguez‐Sillke, Y., Kunkel, D., Schümann, M., Böttcher, C., Stahl‐Hennig, C., et al. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00437-z · Cited by 84

Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution

Kumar, R., Verma, H., Singhvi, N., Sood, U., Gupta, V., Singh, M., KUMARI, R. R., Hira, P., Nagar, S., Talwar, C., et al. (2020) · mSystems · doi:10.1128/msystems.00505-20 · Cited by 81

Carotid stiffness, intima–media thickness and aortic augmentation index among adults with SARS‐CoV‐2

Szeghy, R. E., Province, V. M., Stute, N. L., Augenreich, M. A., Koontz, L. K., Stickford, J. L., Stickford, A. S. L., & Ratchford, S. M. (2021) · Experimental Physiology · doi:10.1113/ep089481 · Cited by 81

Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients

Teixeira, P. C., Dorneles, G. P., Filho, P. S., da Silva, I. M., Schipper, L. L., Postiga, I. A. L., Neves, C. A. M., Rodrigues, L. C., Peres, A., de Souto, J. T., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108125 · Cited by 83

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

Rossi, N. D., Scarpazza, C., Filippini, C., Cordioli, C., Rasia, S., Mancinelli, C. R., Rizzoni, D., Romanelli, G., Cossi, S., Vettoretto, N., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100459 · Cited by 80

Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy

Russo, E., Esposito, P. B., Taramasso, L., Magnasco, L., Saio, M., Briano, F., Russo, C., Dettori, S., Vena, A., Biagio, A. D., et al. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00875-1 · Cited by 80

Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?

Verkhratsky, A., Li, Q., Melino, S., Melino, G., & Shi, Y. (2020) · Biology Direct · doi:10.1186/s13062-020-00282-3 · Cited by 81

Understanding the pathophysiological changes via untargeted metabolomics in COVID‐19 patients

Doğan, H. O., Şenol, O., Bolat, S., Yıldız, Ş. N., Büyüktuna, S. A., Sarıismailoğlu, R., Doğan, K., Hasbek, M., & Hekim, S. N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26716 · Cited by 78

Implications of SARS‐CoV‐2 infection for neurogastroenterology

Marasco, G., Lenti, M. V., Cremon, C., Barbaro, M. R., Stanghellini, V., Sabatino, A. D., & Barbara, G. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14104 · Cited by 78

Neurological involvement in SARS-CoV-2 infection: A clinical systematic review

Scoppettuolo, P., Borrelli, S., & Naeije, G. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100094 · Cited by 78

Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses

Kosuge, M., Furusawa-Nishii, E., Ito, K., Saito, Y., & Ogasawara, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-74843-x · Cited by 78

The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection

Qudus, M. S., Tian, M., Sirajuddin, S., Liu, S., Afaq, U., Wali, M., Liu, J., Pan, P., Luo, Z., Zhang, Q., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28751 · Cited by 84

Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?

Vivarelli, S., Falzone, L., Grillo, C. M., Scandurra, G., Torino, F., & Libra, M. (2020) · Cancers · doi:10.3390/cancers12082237 · Cited by 75

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Dhaiban, S., Al‐Ani, M., Elemam, N. M., & Maghazachi, A. A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s270872 · Cited by 75

COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic Review

Trimboli, P., Cappelli, C., Croce, L., Scappaticcio, L., Chiovato, L., & Rotondi, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.707726 · Cited by 75

NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors

Kandasamy, M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-02035-5 · Cited by 76

Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity

Mehrabadi, M. E., Hemmati, R., Tashakor, A., Homaei, A. A., Yousefzadeh, M., Hemati, K., & Hosseinkhani, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111363 · Cited by 75

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives

Dalamaga, Μ., Christodoulatos, G. S., Karampela, Ι., Vallianou, N. G., & Apovian, C. M. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00436-y · Cited by 74

Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection

Tripathy, A. S., Vishwakarma, S., Trimbake, D., Gurav, Y. K., Potdar, V. A., Mokashi, N. D., Patsute, S. D., Kaushal, H., Choudhary, M. L., Tilekar, B. N., et al. (2021) · Archives of Virology · doi:10.1007/s00705-021-05247-z · Cited by 74

Hematological changes associated with COVID‐19 infection

Al‐Saadi, E. A. K. D., & Abdulnabi, M. A. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24064 · Cited by 74

Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead

Russell, S. M., Alba-Patiño, A., Barón, E., Borges-Sa, M., González‐Freire, M., & de la Rica, R. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00979 · Cited by 73

Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2

Liu, J., Lü, F., Chen, Y., Plow, E. F., & Qin, J. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101710 · Cited by 76

Potential relationships between COVID-19 and the thyroid gland: an update

Naguib, R. (2022) · Journal of International Medical Research · doi:10.1177/03000605221082898 · Cited by 76

Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection

Vahabi, M., Ghazanfari, T., & Sepehrnia, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109183 · Cited by 73

SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases

Murugan, A. K., & Alzahrani, A. S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s332705 · Cited by 72

Investigating the possible mechanisms of autonomic dysfunction post-COVID-19

Jammoul, M., Naddour, J., Madi, A., Reslan, M. A., Hatoum, F., Zeineddine, J., Abou-Kheir, W. G., & Lawand, N. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.103071 · Cited by 76

The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review

Aucoin, M., Cooley, K., Saunders, P. R., Carè, J., Anheyer, D., Medina, D. N., Cardozo, V., Remy, D., Hannan, N., & Garber, A. (2020) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2020.07.004 · Cited by 71

Autoimmunity as the comet tail of COVID-19 pandemic

Talotta, R., & Robertson, E. S. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i17.3621 · Cited by 69

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms

Khan, M. A., Khan, Z. A., Charles, M. R., Pratap, P. D., Naeem, A., Siddiqui, Z., Naqvi, N., & Srivastava, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s271292 · Cited by 71

Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19

Augusti, P. R., Conterato, G. M. M., Denardin, C. C., Prazeres, I. D., Serra, T., Bronze, M. R., & Emanuelli, T. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108787 · Cited by 72

The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection

Campi, I., Bulgarelli, I., Dubini, A., Perego, G. B., Tortorici, E., Torlasco, C., Torresani, E., Rocco, L., Persani, L., & Fugazzola, L. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1391 · Cited by 68

Thymus Degeneration and Regeneration

Duah, M., Li, L., Shen, J., Lan, Q., Pan, B., & Xu, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706244 · Cited by 71

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer

Wu, Q., Tu, H., & Li, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.914730 · Cited by 68

Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics

Rezkalla, S. H., & Kloner, R. A. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.12.007 · Cited by 69

Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases

Sher, E. K., Ćosović, A., Džidić-Krivić, A., Farhat, E. K., Pinjić, E., & Sher, F. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121531 · Cited by 67

Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

Pedrosa, M. A., Valenzuela, R., Garrido‐Gil, P., Labandeira, C. M., Navarro, G., Franco, R., Labandeira-García, J. L., & Rodriguez-Perez, A. I. (2021) · Clinical Science · doi:10.1042/cs20201511 · Cited by 66

A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study

Wang, Z., Li, K., Maskey, A., Huang, W., Toutov, A. A., Yang, N., Srivastava, K. D., Geliebter, J., Tiwari, R. K., Miao, M., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001792r · Cited by 67

Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table

Ranjbar, M., Rahimi, A. R., Baghernejadan, Z., Ghorbani, A., & Khorramdelazad, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109325 · Cited by 67

Molecular mechanisms involved in the positive effects of physical activity on coping with COVID-19

Nigro, E., Polito, R., Alfieri, A., Mancini, A., Imperlini, E., Elce, A., Krustrup, P., Orrù, S., Buono, P., & Daniele, A. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04484-5 · Cited by 67

Exploring the Potential of Carbon Dots to Combat COVID-19

Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Alhakamy, N. A., Md, S., Nair, A. B., & Deb, P. K. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.616575 · Cited by 66

Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes

Güney, C., & Akar, F. (2021) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps31455 · Cited by 66

Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments

Gurunathan, S., Kang, M.-H., & Kim, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716407 · Cited by 67

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients

Mantovani, S., Daga, S., Fallerini, C., Baldassarri, M., Benetti, E., Picchiotti, N., Fava, F., Gallì, A., Zibellini, S., Bruttini, M., et al. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00157-1 · Cited by 65

Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections

Wang, Y., Liu, S., Li, L., Li, L., Zhou, X., Wan, M., Lou, P., Zhao, M., Lv, K., Yuan, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.063 · Cited by 68

COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?

Oliviero, A., de Castro, F., Coperchini, F., Chiovato, L., & Rotondi, M. (2020) · The Neuroscientist · doi:10.1177/1073858420939033 · Cited by 64

Pathogenetic profiling of COVID-19 and SARS-like viruses

Nain, Z., Rana, H. K., Lió, P., Islam, S. M. S., Summers, M. A., & Moni, M. A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa173 · Cited by 64

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19

Baby, K., Maity, S., Mehta, C. H., Suresh, A., Nayak, U. Y., & Nayak, Y. (2020) · F1000Research · doi:10.12688/f1000research.26359.1 · Cited by 65

Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)

Vivarelli, S., Falzone, L., Torino, F., Scandurra, G., Russo, G. L., Bordonaro, R., Pappalardo, F., Spandidos, D. A., Raciti, G., & Libra, M. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5159 · Cited by 64

Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?

Vignesh, R., Swathirajan, C. R., Tun, Z. H., Rameshkumar, M. R., Solomon, S. S., & Balakrishnan, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607734 · Cited by 66

Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection

Cui, Z., Zeng, C., Huang, F., Yuan, F., Yan, J., Zhao, Y., Zhou, Y., Hankey, W., Jin, V. X., Huang, J., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01094-4 · Cited by 65

Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid-19

Fischer, L., Barop, H., Ludin, S. M., & Schaible, H. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102903 · Cited by 64

Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis

Schultz, I. C., Bertoni, A. P. S., & Wink, M. R. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10122-0 · Cited by 62

Convalescent-plasma-transfusion intelligent framework for rescuing COVID-19 patients across centralised/decentralised telemedicine hospitals based on AHP-group TOPSIS and matching component

Mohammed, T. J., Albahri, A. S., Zaidan, A. A., Albahri, O. S., Al‐Obaidi, J. R., Zaidan, B. B., Larbani, M., Mohammed, R. T., & Hadi, S. M. (2021) · Applied Intelligence · doi:10.1007/s10489-020-02169-2 · Cited by 62

Paper-Based Biosensors for COVID-19: A Review of Innovative Tools for Controlling the Pandemic

Pinheiro, T., Cardoso, A. R. A., Sousa, C. E. A., Marques, A. C., Tavares, A. P. M., Matos, A. M., Cruz, M. T., Moreira, F. T. C., Martins, R., Fortunato, E. M. C., et al. (2021) · ACS Omega · doi:10.1021/acsomega.1c04012 · Cited by 62

COVID-19 and myocarditis: a review of literature

Ali, M., Shiwani, H. A., Elfaki, M. Y., Hamid, M., Pharithi, R. B., Kamgang, R., Egom, C. B.-A., Oyono, J. L. E., & Egom, E. E. A. (2022) · The Egyptian Heart Journal · doi:10.1186/s43044-022-00260-2 · Cited by 62

Alterations of Lipid Profile in COVID-19: A Narrative Review

Rezaei, A., Neshat, S., & Heshmat‐Ghahdarijani, K. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100907 · Cited by 63

Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis

Eltobgy, M. M., Zani, A., Kenney, A. D., Estfanous, S. Z. K., Kim, E., Badr, A., Carafice, C., Daily, K. P., Whitham, O. D., Pietrzak, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202012119 · Cited by 62

Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19

Grodecki, K., Lin, A., Razipour, A., Cadet, S. J., McElhinney, P. A., Chan, C., Pressman, B. D., Julien, P. J., Maurovich‐Horvat, P., Gaibazzi, N., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154436 · Cited by 61

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Rogiers, A., da Silva, I. P., Tentori, C., Tondini, C. A., Grimes, J. M., Trager, M. H., Nahm, S. H., Zubiri, L., Manos, M. P., Bowling, P. J., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001931 · Cited by 60

Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients

Taniguchi‐Ponciano, K., Vadillo, E., Mayani, H., González-Bonilla, C. R., Torres, J., Majluf, A., Flores, G., Wacher, N. H., Galan, J. C., Ferat-Osorio, E. A., et al. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1858234 · Cited by 59

Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)

Choreño-Parra, J. A., Jiménez-Álvarez, L. A., Cruz‐Lagunas, A., Rodríguez-Reyna, T. S., Ramírez-Martínez, G., Sandoval-Vega, M., Hernández-García, D. L., Choreño-Parra, E. M., Balderas-Martínez, Y. I., Martínez-Sánchez, M. E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.593595 · Cited by 62

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes

Ahmadi, P., Hartjen, P., Kohsar, M., Kummer, S., Schmiedel, S., Bockmann, J., Fathi, A., Huber, S., Haag, F., & Wiesch, J. S. Z. (2020) · Cells · doi:10.3390/cells9081750 · Cited by 58

The Potential Roles of Jamu for COVID-19: A Learn from the Traditional Chinese Medicine

Hartanti, D., Dhiani, B. A., Charisma, S. L., & Wahyuningrum, R. (2020) · Pharmaceutical Sciences and Research · doi:10.7454/psr.v7i4.1083 · Cited by 58

Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality

Sakuraba, A., Haider, H., & Sato, T. (2020) · Viruses · doi:10.3390/v12111333 · Cited by 59

Thyroiditis and SARS-CoV-2 pandemic: a review

Caron, P. J. (2021) · Endocrine · doi:10.1007/s12020-021-02689-y · Cited by 58

Molecular Mechanism of the Anti-Inflammatory Action of Heparin

Litov, L., Petkov, P., Rangelov, M. A., Ilieva, N., Lilkova, E., Todorova, N. H., Krachmarova, E., Malinova, K., Gospodinov, A. G., Hristova, R. H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910730 · Cited by 58

Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells

Shaharuddin, S. H., Wang, V., Santos, R. D. S., Gross, A. R., Wang, Y., Jawanda, H., Zhang, Y., Hasan, W., Garcia, G., Arumugaswami, V., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.678482 · Cited by 57

Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II

Fathi-Kazerooni, M., Ghazi, S. F., Darzi, M., Makarem, J., Nasiri, R., Salahshour, F., Manshadi, S. A. D., & Kazemnejad, S. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02771-w · Cited by 57

SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome

Zaffagni, M., Harris, J. M., Patop, I. L., Pamudurti, N. R., Nguyen, S., & Kadener, S. (2022) · eLife · doi:10.7554/elife.71945 · Cited by 58

COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route

Mingoti, M. E. D., Bertollo, A. G., Simões, J. L. B., Francisco, G. R., Bagatini, M. D., & Ignácio, Z. M. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02004-y · Cited by 60

Green Tea Polyphenol Catechins Inhibit Coronavirus Replication and Potentiate the Adaptive Immunity and Autophagy-Dependent Protective Mechanism to Improve Acute Lung Injury in Mice

Yang, C.-C., Wu, C., Chien, C.-Y., & Chien, C. (2021) · Antioxidants · doi:10.3390/antiox10060928 · Cited by 56

A contemporary review on pathogenesis and immunity of COVID-19 infection

Mirzaei, R., Karampoor, S., Sholeh, M., Moradi, P., Ranjbar, R., & Ghasemi, F. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05621-1 · Cited by 57

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

Pum, A., Ennemoser, M., Adage, T., & Kungl, A. J. (2021) · Biomolecules · doi:10.3390/biom11010091 · Cited by 89

The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved

Coperchini, F., Chiovato, L., Ricci, G., Croce, L., Magri, F., & Rotondi, M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.005 · Cited by 135

Immune Profiling of COVID-19 in Correlation with SARS and MERS

Khalil, B. A., Shakartalla, S. B., Goel, S., Mdkhana, B., Halwani, R., Maghazachi, A. A., AlSafar, H. S., Al‐Omari, B., & Bataineh, M. T. A. (2022) · Viruses · doi:10.3390/v14010164 · Cited by 18

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections

Liu, T., Feng, M., Wen, Z., He, Y., Lin, W., & Zhang, M. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s329697 · Cited by 29

An enlightening role for cytokine storm in coronavirus infection

Zhao, Z., Wei, Y., & Tao, C. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108615 · Cited by 48